Implantation of Gold Beads to Relieve Discomfort From Knee Osteoarthritis

Sponsor
Research Unit Of General Practice, Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT00487370
Collaborator
(none)
43
1
21
2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether implanting gold beads extraarticularly in five acupuncture-points around a knee improves pain, stiffness and function in patients with knee osteoarthritis.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Implantation of gold beads around a knee through needles
  • Procedure: Sham implantation: Insertion of needles around a knee
N/A

Detailed Description

Osteoarthritis (OA) is one of the most common diagnoses made in general practice and among the most common causes of disability in older people. Acupuncture is a well-founded supplement or alternative to pharmacological and surgical treatment methods. The improvement is, however, often brief, so to preserve the initial effect the acupuncture has to be repeated at regular intervals.

In veterinarian medicine implantation of gold-beads in acupuncture-points around a joint has been used mostly in dogs for at least 30 years in the treatment of OA. The effect measured on eating pattern, physical activity and signs of pain last for several years. It may be hypothesized that implanting gold in acupuncture points acts as a continuous acupuncture stimulation.

The purpose of this one year randomised, controlled trial of middle-aged and elderly patients is to examine the effect of implanting gold beads extraarticularly in five acupuncture-points around a knee with OA.

Study Design

Study Type:
Interventional
Actual Enrollment :
43 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Extraarticular Gold Implantation for Treatment of Knee Osteoarthritis.
Study Start Date :
Mar 1, 1997
Actual Study Completion Date :
Dec 1, 1998

Outcome Measures

Primary Outcome Measures

  1. Pain from the knee osteoarthritis is evaluated by the patient with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). [0, 1, 3, 6, 9, and 12 months]

  2. Stiffness is evaluated with the WOMAC questionnaire. [0, 1, 3, 6, 9, and 12 months]

  3. Function is evaluated with the WOMAC questionnaire. [0, 1, 3, 6, 9, and 12 months]

  4. The same orthopaedic surgeon assesses the patients knee score using the Knee Society Clinical Rating System. [0, 6, and 12 months]

  5. The same orthopaedic surgeon assesses the patients function score using the Knee Society Clinical Rating System. [0, 6, and 12 months]

Secondary Outcome Measures

  1. The effect of the initial screening by conventional acupuncture - in relation to the five primary outcome measures. [2 months before randomisation]

  2. Side-effects and discomfort from the implantation, primarily whether the implanted gold beads will migrate during the study period. [The entire study period]

  3. The time from implantation until the effect possibly sets in. [The entire study period]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-80 years

  • Clinically diagnosed and radiologically verified knee osteoarthritis (OA)

  • Pain and stiffness derived from OA lasting for more than one year

Exclusion Criteria:
  • Previous knee trauma (OA following previous meniscectomy is included)

  • Other rheumatologic conditions like rheumatoid arthritis or fibromyalgia

  • Pronounced hip OA

  • Severe somatic or mental illnesses

  • Dementia

  • Alcohol or drug abuse

  • Pregnancy

  • Anticoagulant treatment

  • Corticosteroid treatment during the last 3 months

  • Allergy to chlorhexidine or local anaesthetics

Contacts and Locations

Locations

Site City State Country Postal Code
1 General practice Holte Denmark DK-2840

Sponsors and Collaborators

  • Research Unit Of General Practice, Copenhagen

Investigators

  • Principal Investigator: Kirsten Nejrup, MD, General practice, DronninggĂ„rds Alle 2 B, DK-2840 Holte, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00487370
Other Study ID Numbers:
  • KN1996
First Posted:
Jun 18, 2007
Last Update Posted:
Jun 18, 2007
Last Verified:
Jun 1, 2007

Study Results

No Results Posted as of Jun 18, 2007